Skip to main content
James Ip, MD, Cardiology, New York, NY, New York-Presbyterian Hospital

JamesEIpMD

Cardiology New York, NY

Cardiac Electrophysiology

Professor, Weill Cornell Medical College

Overview of Dr. Ip

Dr. James Ip is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from Harvard Medical School and has been in practice 13 years. Dr. Ip accepts several types of health insurance, listed below. He is one of 690 doctors at New York-Presbyterian Hospital and one of 690 doctors at New York-Presbyterian Hospital who specialize in Cardiology. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Clinical Cardiac Electrophysiology, 2010 - 2011
  • New York Presbyterian Hospital(Cornell Campus)/Coney Island Hospital
    New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2007 - 2010
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2004

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2024
  • MA State Medical License
    MA State Medical License 2006 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Milestone Pharmaceuticals Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA Scientific Sessions 2022
    Milestone Pharmaceuticals Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA Scientific Sessions 2022November 7th, 2022
  • Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT
    Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVTApril 30th, 2022
  • Effective Nasal Spray Therapy for Recurrent Abnormal Heart Rhythms
    Effective Nasal Spray Therapy for Recurrent Abnormal Heart RhythmsApril 13th, 2024
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment